Zunahme der Häufigkeit medikamentöser Behandlungen, ethische Prinzipien und Interessenkonflikte in der Kooperation mit der pharmazeutischen Industrie

Literatur

• Albayrak, Ö. , Albrecht, B. , Scherag, S. , Barth, N. , Hinney, A. , Hebebrand, J. (2011). Successful methylphenidate treatment of early onset extreme obesity in a child with a melanocortin-4 receptor gene mutation and attention deficit/hyperactivity disorder. European Journal of Pharmacology, 660, 165–170. First citation in articleCrossref Medline, Google Scholar

• AOK Rheinland/Hamburg . (2011). Pressemitteilung vom 30.3.2011. Verfügbar unter www.aok.de/rheinland-hamburg/die-aok/presse-pressemitteilungen-172974.php?action=detail&pressemitteilung=190&lastAction=index First citation in articleGoogle Scholar

• Blech, J. (2011). Seelsorge für die Industrie. www.spiegel.de/spiegel/print/d-78522323.html First citation in articleGoogle Scholar

• Copeland, E. J. , Shanahan, L. , Costello, E. J. , Angold, A. (2011). Cumulative prevalence of psychiatric disorders by adulthood: A prospective cohort analysis from the Great Smoky Mountains Study. Journal of the American Academy of Child and Adolescent Psychiatry, 50, 252–261. First citation in articleCrossref Medline, Google Scholar

• Faraone, S. V. , Biederman, J. , Morley, C. P. , Spencer, T. J. (2008). Effect of stimulants on height and weight: A review of the literature. Journal of the American Academy of Child and Adolescent Psychiatry, 47, 994–1009. First citation in articleMedline, Google Scholar

• Frank, R. G. , Conti, R. M. , Goldman, H. H. (2005). Mental health policy and psychotropic drugs. The Milbank Quarterly, 83, 271–98. First citation in articleCrossref Medline, Google Scholar

• Hammerness, P. G. , Surman, C. B. , Chilton, A. (2011). Adult attention-deficit/hyperactivity disorder treatment and cardiovascular implications. Curr Psychiatry Rep, 13, 357–363. First citation in articleCrossref Medline, Google Scholar

• Hazell, P. (2011). The challenges to demonstrating long-term effects of psychostimulant treatment for attention-deficit/hyperactivity disorder. Current Opinion in Psychiatry, 24, 286–290. First citation in articleCrossref Medline, Google Scholar

• Huang, Y. S. , Tsai, M. H. (2011). Long-term outcomes with medications for attention-deficit hyperactivity disorder: Current status of knowledge. CNS Drugs, 25, 539–554. First citation in articleCrossref Medline, Google Scholar

• Institute of Medicine . (2009). www.iom.edu/Reports/2009/Conflict-of-Interest-in-Medical-Research-Education-and-Practice.aspx First citation in articleGoogle Scholar

• Kessler, R. C. , Avenevoli, S. , Costello, E. J. , Georgiades, K. , Green, J. G. , Gruber, M. J. , ... Merikangas, K. R. (2011). Prevalence, persistence, and sociodemographic correlates of DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement. Archives of General Psychiatry. [Epub ahead of print] PMID 22147808. First citation in articleGoogle Scholar

• Köster, I. , Schubert, I. , Lehmkuhl, G. (2008). Projektbericht. Neuroleptika-Verordnung im Kindes- und Jugendalter. Köln: Forschungsgruppe PMV. First citation in articleGoogle Scholar

• Lehmkuhl, U. , die Kommission Ethik und pharmazeutische Industrie . (2006). Leitlinien zur Kooperation zwischen dem Fachgebiet der Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie und der pharmazeutischen Industrie. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie, 34, 303–309. First citation in articleLink, Google Scholar

• Lieb, K. , Klemperer, D. , Ludwig, W.-D. (2011). Einleitung. In K. Lieb, D. Klemperer, W.-D. Ludwig (Hrsg.), Interessenkonflikte in der Medizin. Hintergründe und Lösungsmöglichkeiten (S. 1–10). Heidelberg: Springer. First citation in articleCrossref, Google Scholar

• Lundh, A. , Krogsboll, L. T. , Gotsche, P. C. (2011). Access to data in industry-sponsored trials. Lancet, 378, 1995–1996. First citation in articleCrossref Medline, Google Scholar

• Müller, W. (2010). Empfehlungen der AWMF zum Umgang mit Interessenkonflikten bei Fachgesellschaften. GMS Mitteilungen aus der AWMF, 7, 1–5. Online erhältlich über www.awmf.org/fileadmin/user_upload/Leitlinien/Werkzeuge/empf-coi.pdf First citation in articleGoogle Scholar

• Naber, D. , Leppig, M. , Grohmann, R. , Hippius, H. (1989). Efficacy and adverse effects of clozapine in the treatment of schizophrenia and tardive dyskinesia – a retrospective study of 387 patients. Psychopharmacology, 99(Suppl.), S73–76. First citation in articleGoogle Scholar

• Pramyothin, P. , Khaodhiar, L. (2010). Metabolic syndrome with the atypical antipsychotics. Curr Opin Endocrinol Diabetes Obes, 17, 460–466. First citation in articleCrossref Medline, Google Scholar

• Reyes, M. M. , Panza, K. E. , Martin, A. , Bloch, M. H. (2011). Time lag bias in trials of pediatric antidepressants: A systematic review und meta-analysis. Journal of the American Academy of Child and Adolescent Psychiatry, 50, 63–72. First citation in articleCrossref Medline, Google Scholar

• Safer, D. J. , Zito, J. M. (2011). International patterns of pediatric medication for emotional and behavioral disorders. In A. Martin, L. Scahill, C. J. Kratochvil (Eds.), Pediatric psychopharmacology (2nd ed., pp. 763–774). Oxford: Oxford University Press. First citation in articleGoogle Scholar

• Schlander, M. , Trott, G. E. , Schwarz, O. (2009). Gesundheitsökonomie der Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung in Deutschland. Nervenarzt, 81, 289–300. First citation in articleCrossref, Google Scholar

• Schmitz, T. (2011, 5./6. November). Mach mich lieb. Süddeutsche Zeitung, S. 3. First citation in articleGoogle Scholar

• Schubert, I. , Köster, I. , Lehmkuhl, G. (2010). Prävalenzentwicklung von hyperkinetischen Störungen und Methylphenidatverordnungen. Deutsches Ärzteblatt, 107, 615–621. First citation in articleGoogle Scholar

• Seidler, E. (2004). Zappelphillip und ADHS – Von der Unart zur Krankheit. Deutsches Ärzteblatt, 101, A-239. First citation in articleGoogle Scholar

• Shaw, P. , Sharp, W. S. , Morrison, M. , Eckstrand, K. , Greenstein, D. K. , Clasen, L. S. , ... Rapoport, J. L. (2009). Psychostimulant treatment and the developing cortex in attention deficit hyperactivity disorder. American Journal of Psychiatry, 166, 58–63. First citation in articleCrossref Medline, Google Scholar

• Truyers, C. , Buntinx, F. , De Lepeleire, J. , De Hert, M. , Van Winkel, R. , Aertgeerts, B. , ... Lesaffre, E. (2011). Incident somatic comorbidity after psychosis: Results from a retrospective cohort study based on Flemish general practice data. BMC Family Practice, 12, 132. First citation in articleCrossref Medline, Google Scholar

• Wikipedia . (2012). en.wikipedia.org/wiki/Olanzapine#Controversy.2C_lawsuits_and_settlements First citation in articleGoogle Scholar

• Wilson, D. (2010). Side effects may include lawsuits. New York Times. www.nytimes.com/2010/10/03/business/03psych.html?pagewanted=1 First citation in articleGoogle Scholar

• Wittchen, H. U. , Jacobi, F. , Rehm, J. , Gustavsson, A. , Svensson, M. , Jönsson, B. , ... Steinhausen, H. C. (2011). The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol, 21, 655–679. First citation in articleCrossref Medline, Google Scholar

• Zhang, G. Q. , Zhang, W. (2009). Heart rate, lifespan, and mortality risk. Ageing Res Rev., 8, 52–56. First citation in articleCrossref Medline, Google Scholar

• Zito, J. M. , Safer, D. J. , de Jong-van den Berg, L. T. , Janhsen, K. , Fegert, J. M. , Gardner, J. F. , ... Valluri, S. C. (2008). A three-country comparison of psychotropic medication prevalence in youth. Child and Adolescent Psychiatric Mental Health, 2, 26. First citation in articleCrossref Medline, Google Scholar

• Zuvekas, S. H. , Vitiello, B. (2011). Stimulant medication use in children: A 12-year perspective. American Journal of Psychiatry. [Epub ahead of print]. First citation in articleGoogle Scholar